The Government’s pharmaceutical trade deal with the US could cost NHS England £45billion and cause at least 229,000 deaths over the next decade, experts have warned.
In a move that was criticised by MPs, Sir Keir Starmer agreed last December that Britain would pay the US 25 per cent more for new medicines by 2035 to stop Donald Trump from implementing hefty trade tariffs.
The deal is expected to increase the health service’s annual spending on medicines from around 9.5 per cent of its budget to 12 per cent, at a cost to taxpayers of around £3billion a year.
Lib Dem deputy leader Daisy
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
